Stochastic Biology Group: using maths, stats, and experiments to learn about biology and disease. We love organelles and oDNA, evolution, noise, and inference.
How does AMR evolution vary across pathogens? Regions? Patients? We used EvAM* to take a look. https://t.co/0MlhKAbP13
Inferring evol pathways to multi-drug resistance as transition networks, we use the amazing CABBAGE dataset to learn AMR "roadmaps" across global ESKAPEEs... 1/
@anshulkundaje But don't you worry, for example, that the AI's bias will itself bias the human reading it, in a way that has never involved an accountable party? I appreciate current LLMs are good at *spotting errors*, but if opaque cues give them (and thereby us) an opaque...
@HelixMind_ Yup, phenotype profiles paired with accessions for genome data (we exploit the genomes for phylogenetic relatedness, but the phenotypes for the resistomes). Not all bug/drug combinations measured together of course, but definitely a powerful resource!
@HelixMind_ Yes, we've seen the same. One nice thing about the CABBAGE dataset is its explicitly phenotypic resistome profiles -- so each observation can be traced back to a lab result, which CABBAGE has curated and attempted to systematise https://t.co/zv93Ne3afL
... across several decades of clinical study. Would love to hear feedback, and on the aligned work on Klebsiella natural histories https://t.co/5daVwr8IBw and on *the perspective of EvAM in AMR evolution https://t.co/7AW5Jn1lTN 3/
How does AMR evolution vary across pathogens? Regions? Patients? We used EvAM* to take a look. https://t.co/0MlhKAbP13
Inferring evol pathways to multi-drug resistance as transition networks, we use the amazing CABBAGE dataset to learn AMR "roadmaps" across global ESKAPEEs... 1/
... finding striking similarities of evol dynamics across different pathogens, but also diffs predicted by geography and patient demographics. The networks (grey) are predictive, and perform well forecasting new resistome phenotypes (coloured dots) from sub-Saharan Africa... 2/
... finding that the trained models do well at predicting multi-drug resistance states over several decades of clinical sampling. Related: Klebsiella-focussed natural history https://t.co/5daVwr8IBw and *EvAM-AMR perspective https://t.co/7AW5Jn1lTN
... finding remarkable consistency across pathogen evolutionary "roadmaps", but some notable diffs which covary with region and patient demography. The inferred roadmaps also predict unseen and future resistance states, which we test with new data from sub-Saharan Africa... 2/
Mitochondria and chloroplasts are inherited through a "bottleneck". Smaller bottleneck ➡️ more powerful segregation of DNA damage. So why don't organisms just always use a bottleneck of size 1? And what's up with paternal leakage, DUI, etc? Take a look!
https://t.co/BGrWIqrDnL
Super grateful to @RCG_Heretic (and maker @NeuroWoodworks) for this beautiful art celebrating Robert's successful PhD defence! Featuring Eqn. 15 https://t.co/lKjq7fI6UO linking physical behaviour of mitochondria and genetic behaviour of mtDNA :-)